SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-23-003595
Filing Date
2023-05-26
Accepted
2023-05-26 16:01:18
Documents
16
Period of Report
2023-05-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_052523.htm   iXBRL 8-K 30267
2 EXHIBIT 10.1 exh_101.htm EX-10.1 440858
3 EXHIBIT 10.2 exh_102.htm EX-10.2 158556
4 PRESS RELEASE exh_991.htm EX-99.1 7760
  Complete submission text file 0001171843-23-003595.txt   969833

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE gnw-20190101.xsd EX-101.SCH 3069
6 XBRL DEFINITION FILE gnw-20190101_def.xml EX-101.DEF 25640
7 XBRL LABEL FILE gnw-20190101_lab.xml EX-101.LAB 34011
8 XBRL PRESENTATION FILE gnw-20190101_pre.xml EX-101.PRE 22139
10 EXTRACTED XBRL INSTANCE DOCUMENT f8k_052523_htm.xml XML 3035
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32001 | Film No.: 23968693
SIC: 2836 Biological Products, (No Diagnostic Substances)